A detailed history of Hill Investment Group Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hill Investment Group Partners, LLC holds 778 shares of LLY stock, worth $580,543. This represents 0.1% of its overall portfolio holdings.

Number of Shares
778
Previous 799 2.63%
Holding current value
$580,543
Previous $702 Million 1.37%
% of portfolio
0.1%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $16,214 - $20,160
-21 Reduced 2.63%
778 $711 Million
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $76,836 - $96,358
-106 Reduced 11.71%
799 $702 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $377,823 - $505,474
-638 Reduced 41.35%
905 $704 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $21,735 - $29,964
50 Added 3.35%
1,543 $829 Million
Q4 2022

Aug 11, 2023

BUY
$321.55 - $374.67 $480,074 - $559,382
1,493 New
1,493 $546 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hill Investment Group Partners, LLC Portfolio

Follow Hill Investment Group Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hill Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hill Investment Group Partners, LLC with notifications on news.